Journal of Clinical Pathways March 16, 2021
Winston Wong, PharmD

Machine learning, artificial intelligence, immunotherapy, genomics, robotic limbs, wearable health-monitoring tech, mRNA vaccines—it is an exciting time in medical research and technology. Yet, we must be mindful that such advances may require a rethinking or reengineering of our underlying infrastructures to integrate new tools, therapies, and programs effectively. Discovering and addressing gaps in our processes and systems will require continued and enhanced collaboration among stakeholders so that all patients can benefit from the latest advances in medicine and technology. The articles in this issue focus on the need for continued care coordination to ensure access to CAR-T therapy, the role of electronic consultations (eConsults) in care, and how pathways
programs are continuing to evolve—clinically and technologically.

Advances in cellular bioengineering are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Pharma / Biotech, Provider, Technology, Wearables
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.
AI degrades our work, nurses say
What If Generative AI Turned To Be A Flop In Healthcare?
Clinicians, staff highlight strategies to enhance virtual diabetes care

Share This Article